Clicky

Impedimed Limited  (IPD)

Description: ImpediMed Limited is an Australia-based company, which is a global provider of medical technology to measure, monitor and manage fluid status and body composition. The principal activities of the Company consist of the development, manufacture and sale of bioimpedance instruments and consumables, and the sale of electronic test and measurement devices. The Company's operating segments include Medical, and Test & Measurement. The Medical segment is a supplier of non-invasive medical devices to over two underserved markets: aiding in the subclinical assessment of individuals at risk of secondary lymphedema, and the monitoring of body composition and hydration. The medical cash-generating unit (CGU) is the core business of the Company. The Test & Measurement segment is a supplier of power precision testing and measuring equipment (T&M). The Company's geographical locations include Australia/rest of world (ROW) and North America.


Keywords: Biology Medical Technology Medical Device Measurement Electrophysiology Cgu Invasive Medical Devices Bioelectrical Impedance Analysis Measurement Devices Power Precision Testing And Measuring Equipment

Home Page: www.impedimed.com

IPD Technical Analysis

50 Parker Court
Pinkenba, QLD 4008
Australia
Phone: 61 7 3860 3700


Officers

Name Title
Mr. Timothy Cruickshank Chief Financial Officer
Mr. Shashi Tripathi COO, CTO & Chief Customer Officer
Mr. Dennis Schlaht Sr. VP of R&D and Technology
Ms. Catherine Kingsford Sr. VP of Medical Affairs
Mr. David W. Anderson B.S. Exec. Director
Mr. Richard P. Valencia MD & CEO
Mr. Michael John Bassett Chief Commercial Officer, Sr. VP of Corp. & Strategic Devel. and GM of Renal
Ms. Nancy T. Deisinger Sr. VP of HR
Dr. Thomas Schenk Chief Medical Officer
Ms. Leanne Ralph AAICD, ACIS, BBus Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 3.1443
Price-to-Sales TTM: 14.5164
IPO Date: 2007-10-24
Fiscal Year End: June
Full Time Employees: 73
Back to stocks